Diabetes, Vol 37, Issue 4 476-481, Copyright © 1988 by American Diabetes Association

ARTICLES

Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). The DCCT Research Group

The Diabetes Control and Complications Trial (DCCT) is a multicenter randomized clinical trial studying the effect of intensive insulin therapy on the early vascular and neurological complications of insulin-dependent diabetes mellitus (IDDM). During the feasibility phase of the DCCT, baseline neurological histories, physical examinations, and laboratory measurements of somatic and autonomic nerve function were obtained in 278 well-characterized IDDM subjects. Subjects were free of advanced complications, including the presence of peripheral or autonomic neuropathy sufficiently severe to require treatment. Analyses of the cross-sectional data reveal that clinically detectable peripheral neuropathy was present in 39% of the subjects. The presence of clinical neuropathy correlated with greater age, longer duration of IDDM, and male gender. The somatic and autonomic test results confirm the relationship between age, diabetes duration, and male gender and diabetic neuropathy. These results support an effect of age and gender on the development of diabetic complications.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. S. Andreassen, J. Jakobsen, and H. Andersen Muscle Weakness: A Progressive Late Complication in Diabetic Distal Symmetric Polyneuropathy Diabetes, March 1, 2006; 55(3): 806 - 812. [Abstract] [Full Text] [PDF]

				C. L. Martin, J. Albers, W. H. Herman, P. Cleary, B. Waberski, D. A. Greene, M. J. Stevens, and E. L. Feldman Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion Diabetes Care, February 1, 2006; 29(2): 340 - 344. [Abstract] [Full Text] [PDF]

				G. Rudofsky Jr, A. Schroedter, A. Schlotterer, O. E. Voron'ko, M. Schlimme, J. Tafel, B. H. Isermann, P. M. Humpert, M. Morcos, A. Bierhaus, et al. Functional Polymorphisms of UCP2 and UCP3 Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients With Type 1 Diabetes Diabetes Care, January 1, 2006; 29(1): 89 - 94. [Abstract] [Full Text] [PDF]

				F. Mohsin, M. E Craig, J. Cusumano, A. K.F. Chan, S. Hing, J. W. Lee, M. Silink, N. J. Howard, and K. C. Donaghue Discordant Trends in Microvascular Complications in Adolescents With Type 1 Diabetes From 1990 to 2002 Diabetes Care, August 1, 2005; 28(8): 1974 - 1980. [Abstract] [Full Text] [PDF]

				A. V. Krishnan and M. C. Kiernan Altered nerve excitability properties in established diabetic neuropathy Brain, May 1, 2005; 128(5): 1178 - 1187. [Abstract] [Full Text] [PDF]

				F. Li, I. G. Obrosova, O. Abatan, D. Tian, D. Larkin, E. L. Stuenkel, and M. J. Stevens Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E29 - E36. [Abstract] [Full Text] [PDF]

				A. J.M. Boulton, R. A. Malik, J. C. Arezzo, and J. M. Sosenko Diabetic Somatic Neuropathies Diabetes Care, June 1, 2004; 27(6): 1458 - 1486. [Full Text] [PDF]

				G. Rudofsky Jr, P. Reismann, S. Witte, P. M. Humpert, B. Isermann, T. Chavakis, J. Tafel, V. V. Nosikov, A. Hamann, P. Nawroth, et al. Asp299Gly and Thr399Ile Genotypes of the TLR4 Gene Are Associated With a Reduced Prevalence of Diabetic Neuropathy in Patients With Type 2 Diabetes Diabetes Care, January 1, 2004; 27(1): 179 - 183. [Abstract] [Full Text] [PDF]

				K. Asao, C. Sarti, T. Forsen, V. Hyttinen, R. Nishimura, M. Matsushima, A. Reunanen, J. Tuomilehto, and N. Tajima Long-Term Mortality in Nationwide Cohorts of Childhood-Onset Type 1 Diabetes in Japan and Finland Diabetes Care, July 1, 2003; 26(7): 2037 - 2042. [Abstract] [Full Text] [PDF]

				A. I. Vinik, R. E. Maser, B. D. Mitchell, and R. Freeman Diabetic Autonomic Neuropathy Diabetes Care, May 1, 2003; 26(5): 1553 - 1579. [Abstract] [Full Text] [PDF]

				Q. Mei, T. O. Mundinger, A. Lernmark, and G. J. Taborsky Jr Early, Selective, and Marked Loss of Sympathetic Nerves From the Islets of BioBreeder Diabetic Rats Diabetes, October 1, 2002; 51(10): 2997 - 3002. [Abstract] [Full Text] [PDF]

				P. H. Riihimaa, K. Suominen, U. Tolonen, V. Jäntti, M. Knip, and P. Tapanainen Peripheral Nerve Function Is Increasingly Impaired During Puberty in Adolescents With Type 1 Diabetes Diabetes Care, June 1, 2001; 24(6): 1087 - 1092. [Abstract] [Full Text]

				H. E. Resnick, A. I. Vinik, H. K. Heimovitz, F. L. Brancati, and J. M. Guralnik Age 85+ Years Accelerates Large-Fiber Peripheral Nerve Dysfunction and Diabetes Contributes Even in the Oldest-Old: The Women's Health and Aging Study J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2001; 56(1): 25M - 31. [Abstract] [Full Text]

				E. Akarsu, I. Pirim, I. Çapoglu, O. Deniz, G. Akçay, and N. Ünüvar Relationship Between Electroneurographic Changes and Serum Ubiquitin Levels in Patients With Type 2 Diabetes Diabetes Care, January 1, 2001; 24(1): 100 - 103. [Abstract] [Full Text]

				E.S. Kilpatrick, B.G. Keevil, C. Jagger, R.J. Spooner, and M. Small Determinants of raised C-reactive protein concentration in type 1 diabetes QJM, April 1, 2000; 93(4): 231 - 236. [Abstract] [Full Text] [PDF]

				The Diabetes Control and Complications Trial Resea The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus N. Engl. J. Med., September 30, 1993; 329(14): 977 - 986. [Abstract] [Full Text]

				D. M. Nathan Long-Term Complications of Diabetes Mellitus N. Engl. J. Med., June 10, 1993; 328(23): 1676 - 1685. [Full Text]